期刊名称：THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY ISSN： 2045-1253 出版频率： Continuous publication 出版社： SAGE PUBLICATIONS LTD, 1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP   出版社网址： https://journals.sagepub.com/ 期刊网址： https://journals.sagepub.com/home/tppa 影响因子： 5 主题范畴： PHARMACOLOGY & PHARMACY;    PSYCHIATRY 变更情况： 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Aims and Scope Therapeutic Advances in Psychopharmacology delivers the highest quality peer-reviewed open access articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in psychopharmacology, providing an online forum for rapid dissemination of recent research and perspectives in this area. The editors welcome original research articles across all areas of psychopharmacology. The journal publishes original research articles and review articles primarily. Letters to the Editor and Case Reports will also be considered. Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. The trial registry name and URL, and registration number must be included at the end of the abstract.   The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees. Abstracting and Indexing This journal is included in the following abstracting and indexing databases. Clarivate Analytics: Current Contents - Clinical Medicine Clarivate Analytics: Current Contents - Life Sciences Clarivate Analytics: Science Citation Index Expanded (SCIE) Directory of Open Access Journals (DOAJ) ProQuest PubMed Central (PMC) Instructions to Authors Manuscript Submission Guidelines:  Manuscript Submission Guidelines: Therapeutic Advances in Psychopharmacology  This Journal is a member of the Committee on Publication Ethics. Please read the guidelines below then visit the Journal’s submission site https://mc.manuscriptcentral.com/tpp to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process. Only manuscripts of sufficient quality that meet the aims and scope of Therapeutic Advances in Psychopharmacology will be reviewed. As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you. Therapeutic Advances in Psychopharmacology may accept submissions of papers that have been posted on pre-print servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the journal. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy. If your paper is accepted, you must include a link on your preprint to the final version of your paper. Open Access Article processing charge (APC) Article Types Editorial policies 4.1 Peer Review Policy 4.2 Authorship 4.3 Acknowledgements 4.4 Funding 4.5 Declaration of conflicting interests 4.6 Research ethics and patient consent 4.7 Clinical Trials 4.8 Reporting guidelines 4.9 Data Publishing policies 5.1 Publication ethics 5.2 Contributor's publishing agreement Preparing your manuscript 6.1 Word processing formats 6.2 Artwork, figures and other graphics 6.3 Supplementary material 6.4 Reference style 6.5 English language editing services Submitting your manuscript 7.1 ORCID 7.2 Information required for completing your submission 7.3 Permissions On acceptance and publication 8.1 SAGE Production 8.2 Continuous publication 8.3 Promoting your article Further information Editorial Board   Editor-in-Chief David Taylor Maudsley Hospital, London, UK Managing Editor Hemi Malkki SAGE Publishing, London, UK Associate Editors Jimmi Nielsen Aalborg University Hospital, Denmark James Stone King’s College London and Imperial College London, London, UK Mark Taylor University of Queensland, Brisbane, Australia Ursula Werneke Umea University, Umea, Sweden Editorial Board David Baldwin University of Southampton, UK Sube Banerjee King's College London, London, UK Thomas Barnes Imperial College London, London, UK Stephen Bazire School of Pharmacy, University of East Anglia, Norwich, UK Antonio Bruno University of Messina, Italy Katharina Domschke Universitätsklinikum Freiburg, Germany Peter Haddad University of Manchester, Manchester, UK Mark Horowitz Prince of Wales Hospital, Sydney, Australia Oliver Howes King's College London, London, UK Eija Kalso University of Helsinki, Finland Shitij Kapur King's College London, London, UK Deanna L. Kelly University of Maryland School of Medicine, Baltimore, MD, USA Tim Lambert University of Sydney, Sydney, NSW, Australia Anne Lingford-Hughes Imperial College London, London, UK Roger S. McIntyre Professor of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada Phil Mitchell University of New South Wales, NSW, Australia Antônio Egidio Nardi Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil Maxine Patel Oxleas NHS Foundation Trust & King's College London, UK Carol Paton Oxleas NHS Foundation Trust, Dartford, UK Jill Rasmussen psi-napse, Dorking, UK Suzanne Reeves University College London, London, UK Dan Siskind The University of Queensland, St Lucia, Queensland, Australia Stephen Stahl University of California, San Diego, CA, USA John Strang National Addiction Centre, London, UK Shuichi Suetani University of Queensland, Brisbane, Australia Mauricio Tohen UT Health Science Center, San Antonio, TX, USA Michael Travis Western Psychiatric Institute and Clinic, Pittsburg, PA, USA Hiroyuki Uchida Keio University Medical School, Tokyo, Japan Eduard Vieta University of Barcelona, Barcelona, Spain Nicola Warren University of Queensland, Brisbane, Australia